CompoAtlas

Calcium et vitamine D 325

Natural health product licensed in Canada

Other names
Neobourne Pharma Calcium 500 & Vitamin D 325
Licence holder
BIOVANTEK
NPN or DIN-HM
80020936
Status
Inactive licence
Licence date
27 July 2010
Revision date
17 May 2022
Form
Comprimé
Route of administration
Orale
Application type
Officinale

If this product were sold in France

A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.

Composition

Medicinal ingredient and sourcePer dosage unit, according to the sourceMaximum per day, adult
Vitamine D

Source : Cholécalciférol

Potency : 325 UI

8.125 µg24.375 µg

Non-medicinal ingredients

Croscarmellose de sodium, Stéarate de magnésium, cellulose, Talc, 2-Propanol, Maltodextrine, Dioxyde de silicium, Polyethylene glycol 8000, Carnauba, Dioxyde de titane, Eau purifiée

PopulationAgeQuantity per servingFrequency
AdultesNot specified1 Comprimé3 Tous les jours

Uses authorised in Canada

Aide au développement et au maintien des os et des dents. Aide à l`absorption et à l`utilisation du calcium et du phosphore. La consommation de calcium, lorsqu`elle s`accompagne d`un apport suffisant en vitamine D, d`une alimentation saine et de la pratique régulière d`une activité physique, peut réduire le risque d`ostéoporose. Contribue au maintien d`une bonne santé. Supplément vitaminique/minéral. Aide à prévenir une carence en calcium.

A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.

Warnings in Canada

No French warning text available in the imported data.

Source

Official Health Canada record, licence 80020936

Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.

Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)

Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)

The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.

List in the official revision dated (register: Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks).

List recorded in 2022. Photograph the packaging to check whether it has changed. Photograph the packaging

List recorded in 2022. Photograph the packaging to check whether it has changed.

Enter to analyse, Shift+Enter for a new line